Latest papers

Bilateral optic neuritis due to isoniazid (INH).

[The association between NAT2 polymorphism and anti-tuberculosis drug-induced hepatitis].

Effects of isoniazid and niacin on experimental wound-healing.

Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.

Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.

Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy.

Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.

NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.

Recording isoniazid preventive therapy delivery to children: operational challenges.

Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.

Drug-induced liver injury: past, present and future.

Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.

[Use of rifampicin plus pyrazinamide for antituberculosis prophylaxis does not increase the risk of severe hepatotoxicity in HIV patients: meta-analysis of randomized controlled clinical trials]

Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.

Elucidating drug-enzyme interactions and their structural basis for improving the affinity and potency of isoniazid and its derivatives based on computer modeling approaches.

Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.

Isoniazid pharmacokinetic studies of the 1960s: considering a higher isoniazid dose in childhood tuberculosis.

Au nanoparticle decorated silicate network for the amperometric sensing of isoniazid

Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.

Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection - United States, 2004-2008.